BOSTON, Aug. 19, 2019 /PRNewswire/ — IDTechEx, a market intelligence and events company focused on emerging technologies, reports that the market for 3D printed medical devices and pharmaceuticals will be worth $6.1 billion by the year 2029. IDTechEx finds this to be a rapidly growing market with compound annual growth rates of up to 18% in certain sub-segments.
For more information please refer to IDTechEx’s report: 3D Printing in the Medical and Dental Industry 2019 – 2029.
As IDTechEx have previously reported, 3D printing is disrupting the way we provide personalized medicine. IDTechEx described the hearing aid industry as one that has been transformed by 3D printing technology – the digital precision afforded by 3D printing has improved patient comfort while simultaneously decreasing manufacturing times. In this article, we discuss additional examples of how 3D printing can disrupt the medical device industry.
3D printing creates invisible braces
3D printing in dentistry is one such high growth market, and one of the most high-profile dental products to be manufactured by 3D printing is the Invisalign transparent orthodontic aligners. These devices are produced by Align Technology, on 3D Systems’ ProX SLA printers. The Invisalign product is designed to be aesthetically appealing, particularly to adult patients who wish to minimize the appearance of orthodontic appliances. Moreover, as a removeable device, the patient has no difficulty with eating, and oral hygiene is simplified. Though these devices may not be suitable to treat every patient, they have been used to treat almost 6 million patients around the world. Many competitors are now seeking to profit from this large and growing market.
3D printing enables affordable prosthetics for growing children
An inspiring movement to emerge is the use of 3D printing to create affordable prosthetics for children. Traditional prosthetics can cost between $5000 and $50,000 and provide an insurmountable financial challenge for parents, as children require a new prosthetic every few months. Charitable organizations such as e-NABLE are using 3D printing to create hands and arms from open source designs to relieve this burden from parents around the world. Not only are the prosthetics affordable, but the lead times are decreased relative to the lengthy customization process of traditional prosthetics. While this application has limited contribution to the overall market value, there are significant unmet needs in the field of prosthetics that are going to be met by 3D printing technology.
IDTechEx have published a series of market intelligence reports related to 3D printing technology and applications. To find out more, please refer to www.IDTechEx.com/research/3D.
To connect with others join us at The IDTechEx Show! USA 2019, November 20 – 21 at the Santa Clara Convention Center, CA. Presenting the latest emerging technologies at one event, with seven concurrent conferences and a single exhibition covering Electric Vehicles, Energy Storage, Graphene, Internet of Things, Printed Electronics, Sensors and Wearable Technology. Please visit www.IDTechEx.com/USA to find out more.
IDTechEx guides your strategic business decisions through its Research, Consultancy and Event products, helping you profit from emerging technologies. For more information on IDTechEx Research and Consultancy contact research@IDTechEx.com or visit www.IDTechEx.com.
Media Contact:
Jessica Abineri
Marketing Assistant
press@IDTechEx.com
+44(0)1223 812300
View original content to download multimedia:http://www.prnewswire.com/news-releases/idtechex-forecasts-6-1-billion-market-for-3d-printed-medical-devices-300903108.html
SOURCE IDTechEx
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…